NCT06888310View on ClinicalTrials.gov

Optimizing Noninvasive assessMent Of DysmEtabolic Compensated Advanced Liver Disease

NARecruitingINTERVENTIONAL
Enrollment

408

Participants

Timeline

Start Date

December 6, 2024

Primary Completion Date

December 1, 2026

Study Completion Date

March 1, 2027

Conditions
NASHNAFLD
Interventions
PROCEDURE

extra blood sampling

search for biomarkers for the prevention of liver disease

Trial Locations (1)

00168

RECRUITING

Fondazione Policlinico Universitario Agostino Gemelli IRCCS, UOC Medicina Interna e Trapianto di Fegato, Roma

All Listed Sponsors
lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER